Clinical Trial Update: Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports safety assessment of T4090 eye drops in patients with ocular hypertension or glaucoma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• T4090

Snippet

Sponsor: Laboratoires Thea | Conditions: Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING